Condition
Fabry
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Unknown2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04724083UnknownPrimary
Inflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease Cardiomyopathy
NCT03362645UnknownPrimary
Diagnostic Value of the Electrocardiogram in Fabry Disease
NCT00437944CompletedPrimary
Relation Between Polymorphism in Genes Related to Kidney Disease and Renal Manifistations in Fabry Disease
Showing all 3 trials